August 24, 2025Open Access

Amphibian-derived peptide analog TBKKG6K: A powerful drug candidate against Candida albicans with anti-biofilm efficacy

View Full Paper

Ask AI

Bookmark

Authors

Discussion

This research shows TB_KKG6K reduces biofilm formation and improves antifungal efficacy against Candida albicans, indicating its therapeutic promise.

TB_KKG6K exhibits potent antifungal activity against C. albicans, showcasing less potential for resistance.
It maintains the effectiveness of standard antifungal drugs like amphotericin B in combination treatments.
The study emphasizes TB_KKG6K's ability to reduce biofilm formation on medical devices, addressing a key clinical issue.
Minimal cytotoxicity in human cells suggests further investigation for TB_KKG6K as a clinical therapeutic.

Schöpf et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

This research shows TB_KKG6K reduces biofilm formation and improves antifungal efficacy against Candida albicans, indicating its therapeutic promise.